DE60111196D1 - Molsidominhaltige oral anzuwendende verabreichungsform mit verzögerter wirkstoffabgabe - Google Patents

Molsidominhaltige oral anzuwendende verabreichungsform mit verzögerter wirkstoffabgabe

Info

Publication number
DE60111196D1
DE60111196D1 DE60111196T DE60111196T DE60111196D1 DE 60111196 D1 DE60111196 D1 DE 60111196D1 DE 60111196 T DE60111196 T DE 60111196T DE 60111196 T DE60111196 T DE 60111196T DE 60111196 D1 DE60111196 D1 DE 60111196D1
Authority
DE
Germany
Prior art keywords
molsidomine
hours
released
angina
molsidomine released
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60111196T
Other languages
English (en)
Other versions
DE60111196T2 (de
Inventor
Jozsef-Michel Geczy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Therabel Pharmaceuticals Ltd
Original Assignee
Therabel Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therabel Pharmaceuticals Ltd filed Critical Therabel Pharmaceuticals Ltd
Publication of DE60111196D1 publication Critical patent/DE60111196D1/de
Application granted granted Critical
Publication of DE60111196T2 publication Critical patent/DE60111196T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE60111196T 2000-02-24 2001-02-22 Molsidominhaltige oral anzuwendende verabreichungsform mit verzögerter wirkstoffabgabe Expired - Lifetime DE60111196T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0002307A FR2805462B1 (fr) 2000-02-24 2000-02-24 Nouvelle forme galenique orale a liberation prolongee de la molsidomine
FR0002307 2000-02-24
PCT/EP2001/002055 WO2001062256A1 (fr) 2000-02-24 2001-02-22 Nouvelle forme galenique orale a liberation prolongee de la molsidomine

Publications (2)

Publication Number Publication Date
DE60111196D1 true DE60111196D1 (de) 2005-07-07
DE60111196T2 DE60111196T2 (de) 2006-05-11

Family

ID=8847342

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60111196T Expired - Lifetime DE60111196T2 (de) 2000-02-24 2001-02-22 Molsidominhaltige oral anzuwendende verabreichungsform mit verzögerter wirkstoffabgabe

Country Status (36)

Country Link
US (1) US7767227B2 (de)
EP (1) EP1265614B1 (de)
JP (1) JP4945043B2 (de)
KR (1) KR100814191B1 (de)
CN (1) CN100396284C (de)
AT (1) ATE296632T1 (de)
AU (2) AU4065301A (de)
BE (1) BE1013487A3 (de)
BG (1) BG66111B1 (de)
BR (1) BRPI0108041B8 (de)
CA (1) CA2400886C (de)
CZ (1) CZ301993B6 (de)
DE (1) DE60111196T2 (de)
DZ (1) DZ3273A1 (de)
EE (1) EE05098B1 (de)
ES (1) ES2241803T3 (de)
FR (1) FR2805462B1 (de)
HK (1) HK1050138B (de)
HR (1) HRP20020692B1 (de)
HU (1) HU229799B1 (de)
IL (2) IL151205A0 (de)
IS (1) IS2446B (de)
MA (1) MA25576A1 (de)
MD (1) MD3119C2 (de)
MX (1) MXPA02008262A (de)
NO (1) NO329495B1 (de)
NZ (1) NZ520691A (de)
OA (1) OA12183A (de)
PL (1) PL201631B1 (de)
PT (1) PT1265614E (de)
RS (1) RS50291B (de)
RU (1) RU2263506C2 (de)
SK (1) SK286313B6 (de)
UA (1) UA73972C2 (de)
WO (1) WO2001062256A1 (de)
ZA (1) ZA200206042B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine
US7803402B2 (en) * 2002-07-06 2010-09-28 Sanjeev Khandelwal Pharmaceutical preparations
FR2868314B1 (fr) * 2004-04-05 2008-10-24 Therabel Pharmaceuticals Ltd Nouvelle utilisation therapeutique de la molsidomine et de ses sels pharmaceutiquement acceptables
EP2468269A1 (de) 2010-11-26 2012-06-27 Universitätsklinikum Münster Nitridoxidspender bei der Behandlung von Nitridoxidmangel-induzierten Störungen der Hirnmikrozirkulation
BE1028879B1 (fr) 2020-12-11 2022-07-12 Europharmaceuticals Comprimé à libération prolongée de la molsidomine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3522191A1 (de) * 1985-06-21 1987-01-15 Cassella Ag Photostabilisierung von sydnoniminen
CN1006522B (zh) * 1986-04-30 1990-01-24 田道制药有限公司 缓放性制剂的制备方法
HU210921B (en) * 1990-03-28 1995-09-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
HU211648A9 (en) * 1990-03-28 1995-12-28 Chinoin Gyogyszer Es Vegyeszet Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same
DE4140192C2 (de) * 1991-12-05 1996-02-29 Alfatec Pharma Gmbh Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen
EP0624370B1 (de) * 1993-05-11 1999-10-06 Hoechst Aktiengesellschaft Galenische Zubereitungen von Molsidomin
AU7255394A (en) * 1993-07-08 1995-02-06 Cygnus Therapeutic Systems Monolithic matrix transdermal delivery system
IT1266565B1 (it) * 1993-07-22 1997-01-09 Ct Lab Farm Srl Composizioni farmaceutiche a rilascio controllato a base di uno o piu' sali farmaceuticamente accettabili dell'acido gamma-idrossi-butirrico.
HU218280B (en) * 1994-04-26 2000-07-28 Cyclodextrin inclusion complexes containing sin-1a which are stable intheir solid state, process for their preparation and pharmaceutical compositions containing the comlexes
DE4443105C2 (de) * 1994-12-03 1997-03-13 Hoechst Ag Verfahren zur Herstellung Molsidomin-haltiger Tabletten
JPH09114680A (ja) * 1995-10-19 1997-05-02 Fuji Xerox Co Ltd シーケンス制御装置
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
CA2302275C (en) * 1997-09-19 2009-12-08 Shire Laboratories, Inc. Solid solution beadlet
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine

Also Published As

Publication number Publication date
HK1050138B (zh) 2005-07-29
BR0108041A (pt) 2002-10-29
RU2002121503A (ru) 2004-03-20
JP4945043B2 (ja) 2012-06-06
ES2241803T3 (es) 2005-11-01
DZ3273A1 (fr) 2001-08-30
NO329495B1 (no) 2010-11-01
EE200200472A (et) 2003-12-15
NZ520691A (en) 2004-07-30
CN1419451A (zh) 2003-05-21
IL151205A0 (en) 2003-04-10
BRPI0108041B8 (pt) 2021-05-25
HU229799B1 (en) 2014-07-28
PL201631B1 (pl) 2009-04-30
BG107027A (bg) 2003-04-30
UA73972C2 (en) 2005-10-17
HUP0300607A3 (en) 2006-02-28
CZ301993B6 (cs) 2010-09-01
IS6504A (is) 2002-08-14
MA25576A1 (fr) 2002-10-01
ATE296632T1 (de) 2005-06-15
BG66111B1 (bg) 2011-05-31
KR20020081323A (ko) 2002-10-26
HRP20020692B1 (en) 2011-10-31
CN100396284C (zh) 2008-06-25
MD3119B2 (en) 2006-08-31
EP1265614A1 (de) 2002-12-18
EE05098B1 (et) 2008-12-15
AU2001240653B9 (en) 2005-10-27
MXPA02008262A (es) 2004-04-05
SK12202002A3 (sk) 2002-12-03
NO20024043L (no) 2002-08-23
CA2400886C (fr) 2011-04-19
KR100814191B1 (ko) 2008-03-17
JP2003523981A (ja) 2003-08-12
AU4065301A (en) 2001-09-03
IS2446B (is) 2008-11-15
YU62202A (sh) 2006-01-16
WO2001062256A1 (fr) 2001-08-30
MD3119C2 (ro) 2007-04-30
HUP0300607A2 (hu) 2003-08-28
NO20024043D0 (no) 2002-08-23
PL357550A1 (en) 2004-07-26
US20030045522A1 (en) 2003-03-06
MD20020212A (en) 2002-12-31
AU2001240653B2 (en) 2005-05-26
BR0108041B1 (pt) 2013-06-18
PT1265614E (pt) 2005-10-31
IL151205A (en) 2011-01-31
SK286313B6 (en) 2008-07-07
CA2400886A1 (fr) 2001-08-30
HRP20020692A2 (en) 2004-02-29
US7767227B2 (en) 2010-08-03
DE60111196T2 (de) 2006-05-11
EP1265614B1 (de) 2005-06-01
OA12183A (fr) 2006-05-09
BE1013487A3 (fr) 2002-02-05
RU2263506C2 (ru) 2005-11-10
ZA200206042B (en) 2003-07-29
HK1050138A1 (en) 2003-06-13
FR2805462A1 (fr) 2001-08-31
RS50291B (sr) 2009-09-08
FR2805462B1 (fr) 2003-08-15

Similar Documents

Publication Publication Date Title
RU2005115855A (ru) Композиция трамадола продлонгированного высвобождением с 24-часовым действием
HUP0302086A2 (hu) Késleltetett hatású orális gyógyászati készítmény és eljárás az előállítására
RS115104A (en) Pramipexole once-daily dosage form
HUP0203204A2 (hu) Orális adagolási forma
RS50924B (sr) Oralni dozni oblici propiverina ili njegovih farmaceutski prihvatljivih soli sa produženim oslobađanjem aktivne materije
RS52577B (en) ONE-DAY OXYCODON FORMULATIONS
AR040709A1 (es) Formulacion de lamotrigina de liberacion prolongada y uso de la misma para su preparacion
WO2007010559A3 (en) Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor
DK1427297T3 (da) Appetitnedsættende procyanidin-holdigt præparat til pattedyr
CY1105168T1 (el) Διφασικη συνθεση με τραμαδολη
HUP0500842A2 (hu) Dronedaront tartalmazó gyógyászati készítmény parenterális adagolásra
DE60111196D1 (de) Molsidominhaltige oral anzuwendende verabreichungsform mit verzögerter wirkstoffabgabe
HRP20160479T1 (hr) Oralni pripravak molsidomina s produljenim otpuštanjem, namijenjen liječenju ateroskleroze
DE60121142D1 (de) Zusammensetzung die paracetamol und niflumic säure enthält
HUP0200148A2 (hu) N-(3',4'-dimetoxi-cinnamoil)antranilsav alkalmazása szívkoszorúér-műtéttel kapcsolatos cardiovascularis események megelőzésére vagy mérséklésére

Legal Events

Date Code Title Description
8364 No opposition during term of opposition